Octyl Octanoate Market Players:
- Symrise AG
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Firmenich SA
- Robertet Group
- Penta Manufacturing Company
- Givaudan SA
- Synerzine, Inc.
- BOC Sciences
- The Good Scents Company
- Merck KGaA
- Novaphene
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2026, the industry size of octyl octanoate is estimated at USD 246.17 million.
The global octyl octanoate market size was around USD 232.96 million in 2025 and is likely to expand at a CAGR of more than 6.3%, surpassing USD 429.15 million revenue by 2035.
Asia Pacific is projected to command a 41% revenue share by 2035 in the octyl octanoate market, propelled by expanding production of additive flavors and fragrances alongside rising demand for flavored products, pharmaceuticals, and processed foods in China and India.
Key players in the market include Bausch Health Companies Inc., Taiwan Liposome Company, Ltd., Ocular Therapeutix, Inc., Kiora Pharmaceuticals, Inc., Graybug Vision Inc., Apellis Pharmaceuticals, Inc., Implanet Company, Aerie Pharmaceuticals Inc., EyePoint Pharmaceuticals, Inc., Protalix BioTherapeutics.
